Cite
HARVARD Citation
Dräger, S. et al. (2023). Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020. Open forum infectious diseases. p. . [Online].